Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
RNA-editing mechanisms, which induce nucleotide substitution in the RNA, increase transcript and protein diversities. Editing dysregulation has been shown to lead to grave outcomes, and transcriptome-wide aberrant RNA editing has been found in tumors. However, little is known about the involvement of editing in other diseases. Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by a loss of tolerance for autoantigens from various tissues and the production of multiple autoantibodies. Here, we show that blood samples from individuals with SLE have abnormally high levels of RNA editing, some of which affect proteins and potentially generate novel autoantigens. We suggest that elevated RNA editing, either by ADARs or APOBECs, may be involved in the pathophysiology of SLE, as well as in other autoimmune diseases, by generating or increasing the autoantigen load, a key requisite for the progression of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · cited 1×
“Moreover, SLE has several characteristics that may promote the immunogenicity of RNA editing, such as the upregulation of epitope presentation pathway by IFNs and the accumulation of dead cell debris (Boehm et al., 1997; Lipsky, 2001; Rusinova et al., 2013; Schroder et al., 2004).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 1×
“Hence, editing can alter splice consensus elements, microRNA seeds, and binding sites, as well as protein coding sequences (Burns et al., 1997; Ekdahl et al., 2012; Higuchi et al., 2000; Rueter et al., 1999).”
BackgroundAicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 2×
“SLE patients usually have creativecommons.org/licenses/by-nc-nd/4.0/). elevated levels of circulating type I IFN and increased expression of both type I and type II IFN-stimulated genes (ISGs) (Chiche et al., 2014; Crow and Manel, 2015; Hagberg and Rönnblom, 2015).”
BackgroundInfluentialMutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Rusinova, I., Forster, S., Yu, S., Kannan, A., Masse, M., Cumming, H., Chapman, R., & Hertzog, P. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1215 · Cited by 878
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Han, L., Diao, L., Yu, S., Xu, X., Li, J., Zhang, R., Yang, Y., Werner, H. M. J., Eterovic, A. K., Yuan, Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.013 · Cited by 542 · cited 2×
“Studies show that elevated levels of ADAR1 usually correlate with higher editing activity, manifested both as higher rates of editing and as editing of non-typical editing sites (Han et al., 2015; Paz-Yaacov et al., 2015).”
BackgroundReduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease
Khermesh, K., D'Erchia, A. M., Barak, M., Annese, A., Wachtel, C., Levanon, E. Y., Picardi, E., & Eisenberg, E. (2016) · RNA · doi:10.1261/rna.054627.115 · Cited by 160 · cited 1×
“The list of editing sites was compiled from previous studies (Khermesh et al., 2016; Pinto et al., 2014; Ramaswami et al., 2012).”
MethodSelf-citation
Cited by
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
RNA modifications: importance in immune cell biology and related diseases
Cui, L., Ma, R., Cai, J., Guo, C., Chen, Z., Yao, L., Wang, Y., Fan, R., Wang, X., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01175-9 · Cited by 405
Di Giorgio, E., & Xodo, L. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917998 · Cited by 39
“The RLR missense mutations observed in these diseases are gain-of-function and lead to exaggerated Type I Interferon response activation (118), probably reinforced by autoantigens generation (74).”
BackgroundInfluentialThe implications of APOBEC3-mediated C-to-U RNA editing for human disease
(2024) · doi:10.1038/s42003-024-06239-w · Cited by 16
Metadata
- Authors
- Roth, S. H., Danan-Gotthold, M., Ben-Izhak, M., Rechavi, G., Cohen, C. J., Louzoun, Y., & Levanon, E. Y.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 23
- Issue
- 1
- Pages
- 50-57
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2796236298
- Cited by
- 92
- References
- 8
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.